Timing of Ocular Hypertension After Pediatric Closed-Globe Traumatic Hyphema: Implications for Surveillance

Theodore Bowe1, Anthony Serina2, Mikhayla Armstrong2

  • 1From Harvard Medical School (T.B., D.Z., A.S.S.); Department of Ophthalmology, Boston Children's Hospital (T.B., A.S., M.A., J.W., D.Z., A.S.S.); Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital (S.J.S, D.Z.); Department of Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, USA (T.B., A.S.S.).

Insights

Ocular hypertension (OHT) is common after pediatric eye injuries. Specific injury characteristics can predict when OHT occurs, aiding in early detection and management.

Area of Science:

  • Ophthalmology
  • Pediatric Medicine
  • Trauma Surgery

Background:

  • Pediatric closed-globe injury (CGI) and traumatic hyphema can lead to serious complications.
  • Ocular hypertension (OHT), an elevation in intraocular pressure, is a significant concern following such injuries.
  • Understanding the timing and predictors of OHT is crucial for effective management in pediatric patients.

Purpose of the Study:

  • To evaluate the timing of ocular hypertension (OHT) development after pediatric closed-globe injury (CGI) and traumatic hyphema.
  • To hypothesize that OHT occurrence varies based on specific injury characteristics.
  • To identify risk factors associated with the timing of OHT.

Main Methods:

  • Retrospective cohort study of pediatric patients (≤18 years) with CGI and traumatic hyphema (2002-2019).
  • Intraocular pressure and injury demographics were abstracted from patient records.
  • OHT was defined as intraocular pressure >21 mm Hg, and timing was categorized into presentation, acute (1-7 days), subacute (8-28 days), and late (>28 days).

Main Results:

  • OHT occurred in 39% of eyes (119/305).
  • OHT manifested at presentation (35), acutely (69), subacutely (35), and late (36).
  • Pupil damage predicted acute OHT; presentation OHT predicted subacute OHT; iridodialysis and cataract predicted late OHT.

Conclusions:

  • Ocular hypertension is a frequent complication following pediatric closed-globe injury and traumatic hyphema.
  • Injury demographics serve as significant predictors for the development of OHT.
  • These findings support the development of a risk-stratification tool for efficient OHT surveillance in pediatric eye trauma.
Abstract

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.0K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
918
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
783